- Home
- FORR vs VOR Comparison
FORR vs VOR Comparison
Compare FORR & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- VOR
- Stock Information
- Founded
- FORR 1983
- VOR 2015
- Country
- FORR United States
- VOR United States
- Employees
- FORR N/A
- VOR N/A
- Industry
- FORR Diversified Commercial Services
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- FORR Consumer Discretionary
- VOR Health Care
- Exchange
- FORR Nasdaq
- VOR Nasdaq
- Market Cap
- FORR 193.5M
- VOR 202.4M
- IPO Year
- FORR 1996
- VOR 2021
- Fundamental
- Price
- FORR $9.75
- VOR $2.42
- Analyst Decision
- FORR
- VOR Buy
- Analyst Count
- FORR 0
- VOR 7
- Target Price
- FORR N/A
- VOR $3.77
- AVG Volume (30 Days)
- FORR 68.4K
- VOR 47.5M
- Earning Date
- FORR 07-29-2025
- VOR 08-07-2025
- Dividend Yield
- FORR N/A
- VOR N/A
- EPS Growth
- FORR N/A
- VOR N/A
- EPS
- FORR N/A
- VOR N/A
- Revenue
- FORR $422,269,000.00
- VOR N/A
- Revenue This Year
- FORR N/A
- VOR N/A
- Revenue Next Year
- FORR $2.04
- VOR N/A
- P/E Ratio
- FORR N/A
- VOR N/A
- Revenue Growth
- FORR N/A
- VOR N/A
- 52 Week Low
- FORR $8.50
- VOR $0.13
- 52 Week High
- FORR $20.62
- VOR $3.29
- Technical
- Relative Strength Index (RSI)
- FORR 45.09
- VOR 73.52
- Support Level
- FORR $9.77
- VOR $2.25
- Resistance Level
- FORR $11.00
- VOR $2.84
- Average True Range (ATR)
- FORR 0.39
- VOR 0.54
- MACD
- FORR -0.01
- VOR 0.10
- Stochastic Oscillator
- FORR 28.21
- VOR 70.92
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.